NYSE:MNK
Delisted
Mallinckrodt plc Stock News
$0.116
+0 (+0%)
At Close: Jul 20, 2022
Will an Opioid Manufacturer Stage a Comeback With This New Venture?
01:26pm, Friday, 01'st May 2020
A billion-dollar market opportunity exists for an opioid manufacturer plagued with lawsuits, but will it be enough for a comeback?
Mallinckrodt (NYSE:MNK) Shares Gap Up to $3.88
07:12am, Friday, 01'st May 2020
Mallinckrodt PLC (NYSE:MNK)’s stock price gapped up prior to trading on Thursday . The stock had previously closed at $3.76, but opened at $3.88. Mallinckrodt shares last traded at $3.88, with a vol
Mallinckrodt to fund trial to test nitric oxide therapy in COVID-19 patients
08:59pm, Thursday, 30'th Apr 20202 more Ohio counties to be subject of another opioid trial
06:26pm, Thursday, 30'th Apr 2020
A judge has added claims from two Ohio counties against pharmacies to the growing list of trials on governments' claims that the drug industry should be held liable for the U.S. opioid epidemic. U.S.
2 more Ohio counties to be subject of another opioid trial
06:26pm, Thursday, 30'th Apr 2020
A judge has added claims from two Ohio counties against pharmacies to the growing list of trials on governments' claims that the drug industry should be held liable for the U.S. opioid epidemic. U.S.
Mallinckrodt plc (NYSE: MNK), a global biopharmaceutical company, announced today that it is supporting an investigator-initiated clinical study at Massachusetts General Hospital evaluating the potent
Mallinckrodt to fund trial to test nitric oxide therapy in COVID-19 patients
12:01pm, Thursday, 30'th Apr 2020
Mallinckrodt Plc said on Thursday it would fund a trial conducted by medical experts, evaluating the potential benefits of its respiratory therapy, INOmax, as a treatment for lung complications in …
Mallinckrodt to fund trial to test nitric oxide therapy in COVID-19 patients
12:00pm, Thursday, 30'th Apr 2020
Mallinckrodt Plc said on Thursday it would fund a trial conducted by medical experts, evaluating the potential benefits of its respiratory therapy, INOmax, as a treatment for lung complications in pat
Beirne Wealth Consulting Services LLC Increases Stake in Mallinckrodt PLC (NYSE:MNK)
09:34am, Wednesday, 29'th Apr 2020
Beirne Wealth Consulting Services LLC increased its position in Mallinckrodt PLC (NYSE:MNK) by 44.4% in the 1st quarter, according to the company in its most recent filing with the SEC. The fund owned
Mallinckrodt (NYSE:MNK) Rating Lowered to Strong Sell at ValuEngine
06:44am, Wednesday, 29'th Apr 2020
Mallinckrodt (NYSE:MNK) was downgraded by ValuEngine from a “sell” rating to a “strong sell” rating in a report released on Wednesday, ValuEngine reports. Several other research firms also rec
Aurinia Taps Cerecor's Miller to Succeed Retiring Chief Financial Officer
11:58pm, Tuesday, 28'th Apr 2020
Aurinia Pharmaceuticals (NASDAQ: ]) announced that Joe Miller would become its new chief financial officer, succeeding Dennis Bourgeault, who is retiring
Analysts Estimate Mallinckrodt (MNK) to Report a Decline in Earnings: What to Look Out for
04:33pm, Tuesday, 28'th Apr 2020
Mallinckrodt (MNK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Analysts Estimate Mallinckrodt (MNK) to Report a Decline in Earnings: What to Look Out for
04:33pm, Tuesday, 28'th Apr 2020
Mallinckrodt (MNK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Global and Chinese Market for Paracetamol 2020, with Company Profiles of Key Players Including Mallinckrodt, Farmson and SPI Pharma
10:28am, Tuesday, 28'th Apr 2020
Dublin, April 28, 2020 -- The "Paracetamol Market Insights 2020, Analysis and Forecast Global and Chinese Market to 2025, by Manufacturers, Regions, Technology,.
